Literature DB >> 32263135

Maximizing the thiol-activated photodynamic and fluorescence imaging functionalities of theranostic reagents by modularization of Bodipy-based dyad triplet photosensitizers.

Jianzhang Zhao1, Ling Huang, Xiaoneng Cui, Shujing Li, Huijian Wu.   

Abstract

To maximize both the activatable singlet oxygen (1O2) production and fluorescence of theranostic photodynamic (PDT) reagents, herein we propose a modularized molecular structural profile, i.e. the intersystem crossing (ISC) and fluorescence functionalities were accomplished with different modules in a dyad, thus enabling the activated 1O2 production yield (ΦΔ, PDT) and the fluorescence yield (ΦF) to both approach 100%. The PDT and the fluorescence were caged with a thiol-cleavable disulfide bond (-S-S-) linker and an electron trap (2,4-dinitrobenzenesulfide, DNBS). This new molecular structural profile is different from that of conventional theranostic PDT reagents, which are based on a single chromophore for both PDT and fluorescence; thus, the limitation of ΦΔ + ΦF = 100% exists for only half of our new molecular profile. To this end, six Bodipy dyads were prepared. The photophysical properties of the dyads were studied with steady state absorption, fluorescence and nanosecond transient absorption spectroscopy. The dyads show weak PDT and luminescence, due to the caging effect. In the presence of thiols (GSH or Cys), cleavage of the disulfide linker and DNBS occurs, and the PDT and fluorescence modules are activated simultaneously (ΦF: 1.3% → 47.6%; ΦΔ: 16.7% → 71.5%). These results are useful in designing activatable PDT/fluorescence imaging theranostic reagents.

Entities:  

Year:  2015        PMID: 32263135     DOI: 10.1039/c5tb01857a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  1 in total

1.  Nanoparticles Yield Increased Drug Uptake and Therapeutic Efficacy upon Sequential Near-Infrared Irradiation.

Authors:  Dong Luo; Xinning Wang; Ethan Walker; Jing Wang; Sarah Springer; Jason Lou; Gopalakrishnan Ramamurthy; Clemens Burda; James P Basilion
Journal:  ACS Nano       Date:  2020-10-22       Impact factor: 18.027

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.